Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings

Abstract
Eco-pharmaceuticals are an emerging solution in the pharmaceutical industry, aimed at reducing environmental impacts through sustainable production, distribution, and disposal practices. The growing concern over pharmaceutical waste, especially in low-resource settings, highlights the need for greener alternatives. Pharmaceutical residues, often not fully removed during conventional wastewater treatments, contribute significantly to water pollution and disrupt aquatic ecosystems. Eco-pharmaceuticals address these issues by using biodegradable materials, environmentally friendly production methods, and safer disposal techniques, thereby reducing the persistence of pharmaceutical contaminants in the environment. Life-Cycle Assessment (LCA) is an essential methodology used to evaluate the environmental impact of pharmaceutical products, considering all stages from raw material extraction to end-of-life disposal. The results of LCA show that eco-pharmaceuticals significantly reduce water pollution potential and carbon emissions when compared to conventional drugs. Additionally, they offer a more resource-efficient alternative by minimizing waste generation during production and ensuring safer end-of-life disposal. Despite the clear environmental benefits, challenges remain in transitioning to eco-pharmaceuticals, particularly in low-resource settings where infrastructure for waste management is limited. Cost and availability of eco-pharmaceuticals may also pose barriers to widespread adoption. However, with appropriate policy interventions, public education, and technological innovations, these challenges can be addressed. This study underscores the potential of eco-pharmaceuticals in mitigating environmental degradation while offering a sustainable and cost-effective alternative to traditional pharmaceuticals, particularly in regions most vulnerable to pollution.
Keywords
How to Cite

Inna Noor Inayati, et al. (2024). Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings. Journal of Health Sciences, Nursing and Nutrition, 1(2). https://doi.org/10.70062/greenhealth.v1i4.266

Inna Noor Inayati; Siti Yuriah; Syed Asif Ali, "Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings," Journal of Health Sciences, Nursing and Nutrition, vol. 1, no. 2, 2024.

Inna Noor Inayati; Siti Yuriah; Syed Asif Ali. "Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings." Journal of Health Sciences, Nursing and Nutrition, vol. 1, no. 2, 2024.

Inna Noor Inayati; Siti Yuriah; Syed Asif Ali. "Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings." Journal of Health Sciences, Nursing and Nutrition 1, no. 2 (2024).

Inna Noor Inayati, et al. (2024) 'Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings', Journal of Health Sciences, Nursing and Nutrition, 1(2). doi: 10.70062/greenhealth.v1i4.266.

Inna Noor Inayati; Siti Yuriah; Syed Asif Ali. Assessing the Environmental Footprint Reduction of Greener Healthcare: Innovative Life-Cycle Analysis of Ecologically Sustainable Pharmaceuticals in Low-Resource Settings. Journal of Health Sciences, Nursing and Nutrition. 2024;1(2).

Artikel Terkait
Tren Sitasi Jurnal